Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04695990
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04695990
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04695990. Randomized; no masking; primary purpose treatment. Start 2021-01-15 (anticipated); primary completion 2022-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction
- Condition
- Heart Failure
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Wenyang Huoxue Decoction
- Intervention (Drug)
- Wenyang Huoxue placebo
- Lead sponsor
- Jun Li
Record details
- Record id
cardio:ct-nct04695990- Content hash
3222c043b8835de40c3ffd6f7e0c514632887d2b3b6a1dd7de755e6b11684b2d